WASHINGTON, Dec 3 (Reuters) - Abbott Laboratories Inc’s (ABT.N) weight-loss drug Meridia should be banned immediately because of heart-related risks, a consumer group said on Thursday in a petition to U.S. regulators.
WASHINGTON, Dec 3 (Reuters) - Abbott Laboratories Inc’s (ABT.N) weight-loss drug Meridia should be banned immediately because of heart-related risks, a consumer group said on Thursday in a petition to U.S. regulators.
